These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21741841)

  • 21. Transmission of maternal muscle-specific tyrosine kinase (MuSK) to offspring: report of two cases.
    Murray EL; Kedar S; Vedanarayanan VV
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):76-9. PubMed ID: 21386774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to therapy in myasthenia gravis with anti-MuSK antibodies.
    Evoli A; Bianchi MR; Riso R; Minicuci GM; Batocchi AP; Servidei S; Scuderi F; Bartoccioni E
    Ann N Y Acad Sci; 2008; 1132():76-83. PubMed ID: 18567856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myasthenia gravis experimentally induced with muscle-specific kinase.
    Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
    Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Titer of anti-muscle-specific receptor tyrosine kinase (MuSK) antibody correlated with symptomatic improvement in response to corticosteroid therapy in a patient with anti-MuSK antibody-positive myasthenia gravis: a case report].
    Nakahama Y; Kawajiri M; Ochi M; Kohara K; Ohta K; Miki T
    Rinsho Shinkeigaku; 2007 Jun; 47(6):356-8. PubMed ID: 17633110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myopathy in Childhood Muscle-Specific Kinase Myasthenia Gravis.
    Kirzinger L; Khomenko A; Schulte-Mattler W; Backhaus R; Platen S; Schalke B
    Pediatr Neurol; 2016 Dec; 65():90-92. PubMed ID: 27697312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myasthenia gravis with anti-MuSK antibody, showing progressive muscular atrophy without blepharoptosis.
    Ishii W; Matsuda M; Okamoto N; Shimojima Y; Yazaki M; Motomura M; Ikeda S
    Intern Med; 2005 Jun; 44(6):671-2. PubMed ID: 16020904
    [No Abstract]   [Full Text] [Related]  

  • 27. Myasthenia gravis patients with anti-MuSK antibodies.
    Zagar M; Vranjes D; Sostarko M; Vogrinc Z; Bilić E; Trbojević Cepe M
    Coll Antropol; 2009 Dec; 33(4):1151-4. PubMed ID: 20102061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dropped head syndrome as prominent clinical feature in MuSK-positive Myasthenia Gravis with thymus hyperplasia.
    Spengos K; Vassilopoulou S; Papadimas G; Tsivgoulis G; Karandreas N; Zambelis T; Manta P
    Neuromuscul Disord; 2008 Feb; 18(2):175-7. PubMed ID: 18053719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases].
    Aubert S; Salort-Campana E; Franques J; Uzenot D; Pouget J
    Rev Neurol (Paris); 2009 Nov; 165(11):901-10. PubMed ID: 19327804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis.
    Oh SJ; Hatanaka Y; Hemmi S; Young AM; Scheufele ML; Nations SP; Lu L; Claussen GC; Wolfe GI
    Muscle Nerve; 2006 Apr; 33(4):500-4. PubMed ID: 16392120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles.
    Kuwabara S; Nemoto Y; Misawa S; Takahashi H; Kawaguchi N; Hattori T
    Acta Neurol Scand; 2007 Feb; 115(2):126-8. PubMed ID: 17212617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversible tongue muscle atrophy accelerated by early initiation of immunotherapy in anti-MuSK myasthenia gravis: A case report.
    Kitamura E; Takiyama Y; Nakamura M; Iizuka T; Nishiyama K
    J Neurol Sci; 2016 Jan; 360():10-2. PubMed ID: 26723963
    [No Abstract]   [Full Text] [Related]  

  • 33. Prepubertal muscle-specific kinase myasthenia with a long and benign natural course.
    Zouvelou V; Velonakis G
    Muscle Nerve; 2016 Jun; 53(6):989. PubMed ID: 26663151
    [No Abstract]   [Full Text] [Related]  

  • 34. Myopathic changes detected by quantitative electromyography in patients with MuSK and AChR positive myasthenia gravis.
    Nikolic A; Basta I; Stojanovic VR; Stevic Z; Peric S; Lavrnic D
    J Clin Neurosci; 2016 May; 27():126-9. PubMed ID: 26778359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.
    Pasnoor M; Wolfe GI; Nations S; Trivedi J; Barohn RJ; Herbelin L; McVey A; Dimachkie M; Kissel J; Walsh R; Amato A; Mozaffar T; Hungs M; Chui L; Goldstein J; Novella S; Burns T; Phillips L; Claussen G; Young A; Bertorini T; Oh S
    Muscle Nerve; 2010 Mar; 41(3):370-4. PubMed ID: 19882635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Musk-antibody positive myasthenia gravis presenting with isolated neck extensor weakness.
    Casasnovas C; Povedano M; Jaumà S; Montero J; Martínez-Matos JA
    Neuromuscul Disord; 2007 Jul; 17(7):544-6. PubMed ID: 17533129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis.
    Shibata-Hamaguchi A; Samuraki M; Furui E; Iwasa K; Yoshikawa H; Hayashi S; Yamada M
    Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Myasthenia gravis and muscle atrophy].
    Sanadze AG; Gilvanova OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(2):79-87. PubMed ID: 33728855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients.
    Li Y; Guptill JT; Russo MA; Massey JM; Juel VC; Hobson-Webb LD; Howard JF; Chopra M; Liu W; Yi JS
    Exp Neurol; 2019 Feb; 312():43-50. PubMed ID: 30472069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.